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from the leadership of the CNS and AANS to the leadership of the American Society for Therapeutic Radiation Oncology.
How does this relate to you? And what can you do to have a positive effect on the ongoing process?
If you are doing SRS in the United States, with very rare exceptions (patients paying cash) you will need to submit a bill with proper CPT coding. If the value of code 61793 is downgraded and/or if SRS comes to be viewed as a form of focused radiation therapy, you will be paid less for your time and effort.
What can you do about it? For starters, the Washington Committee of the AANS recently e-mailed a survey to all members to assess SRS practice patterns. Kudos if you responded. If you did not respond, make sure to do so the next time you receive the survey. The more information available, the better the AANS and CNS leadership can represent your interests.
Treat SRS as Surgery
More importantly, treat SRS like it really is the last "S"-that is, surgery. It is not enough merely to place and remove a stereotactic frame. Neurosurgeons doing SRS should be completely familiar with the indications and limitations of the technique; understand basic principles of radiation physics and radiobiology; take the lead role in target selection, anatomical contouring, and dose selection; review the treatment plan in detail, if not actually create it; and be present for the treatment itself.
We can and must maintain stereotactic radiosurgery as a minimally invasive surgical procedure. This surely is to our patients' benefit. And by doing so we will be able to resolve to our satisfaction the above issues regarding coding and reimbursement.
Tinnitus: The Chronic Pain of the Auditory System
Tinnitus is a fairly common disorder affecting up to 40 million patients in the U.S. population. Of these, 10 percent to 15 percent are severe and refractory cases requiring medical intervention. Conservative management strategies include pharmacotherapy and behavioral/cognitive therapy with very few severe patients finding significant relief. Surgery has also been tried for these cases, mainly focusing on manipulation of the VIIIth nerve by vascular decompression or sectioning. The results for these approaches seem to be most effective in patients with demonstrable vascular compression of the VIIIth nerve by the anterior inferior cerebellar artery and accompanied by a narrow-band frequency hearing loss.
Most patients who present with refractory severe tinnitus, however, have had damage to the cochlear apparatus with profound hearing loss and do not have a compressive vascular etiology. For these patients, treatment options remain few and far between.
Recent investigations with functional imaging have demonstrated that tinnitus is similar to another malady well-known to functional neurosurgeons, chronic neuropathic deafferentative pain. We know that the loss of normal neural input, be it from peripheral causes (such as brachial plexus avulsion) or central causes (cortical stroke), results in maladaptive patterns of activity in the sensorimotor thalamocortical circuitry. For example, in patients with phantom limb pain, fMRI and MEG has demonstrated a functional reorganization of the sensory homunculus in which areas subserving the painful amputated limb are invaded by adjacent areas subserving normal body parts. Furthermore, MEG has demonstrated that loss of normal afferent activity to the thalamus results in an aberrant oscillation between thalamus and cortex in chronic pain states. Similarly, fMRI and MEG have demonstrated tonotopic reorganization of auditory cortex in patients with chronic tinnitus, and PET has shown rCBF abnormalities in the auditory cortex of tinnitus patients. Findings such as these raise the question, "Is tinnitus the chronic pain of the auditory system?"
Recently neuromodulation techniques have been applied to the treatment of refractory tinnitus. On the noninvasive side of the spectrum, rTMS has been investigated as a possible intervention. Taking the insight of rTMS one step further, epidural and subdural cortical stimulation has been investigated. Utilizing a model similar to motor cortex stimulation for chronic pain, DeRidder et al. published their encouraging results in the Journal of Neurosurgery in 2004. A feasibility study of this technique in the United States by Northstar Neuroscience is currently concluding. Finally, DBS has also been explored. A group from the Henry Ford Medical System presented its results at a recent neuro-otology meeting. This investigation used DBS leads targeted to the deep white matter of Heschl's gyrus to alleviate refractory tinnitus symptoms.
Tinnitus represents another front in the neuromodulation war against refractory neurological disorders. Insight gained in this arena will be of tremendous benefit to patients without other avenues of relief. Its physiological relationship to deafferentation models of pain may mean that gains made in this disorder may translate to the far larger body of patients with refractory neuropathic pain.
Brian H. Kopell, MD
A decade has passed since the first publications on intraoperative MRI appeared. These were the result of years of theorizing, planning, construction, and early clinical experience. As with any new technology, the birth of iMRI was accompanied by a large "gee-whiz" factor. Especially for those of us who lived through the introduction of diagnostic MRI, the notion that you could actually obtain these images during surgery was unbelievable at first. The ingenuity of the different iMRI solutions, ranging from fixed room solutions, to high field units on ceiling tracks, to compact MR imagers the size of a home theater system, added to the excitement.
A sizable literature, peer-reviewed and otherwise, has been published on the use of iMRI. Without exception these have been retrospective, single-center reviews. Most patients in these series have had intracranial tumors. This reflects the difficulty of applying iMRI to spinal surgery (because of limitations in receiving coil technology and patient positioning) and the continued ergonomic obstacles in the actual use of iMRI. Small series have discussed iMRI in the management of hydrocephalus or in functional stereotactic neurosurgery, but the paucity of these reports merely underscores the difficulty of doing surgery in the iMRI environment.
What have we learned from these reports? More or less, about 33 percent of patients having iMRI-guided surgery for brain tumors have additional resection based on intraoperative images. Complication avoidance thanks to iMRI has been reported in as many of 14 percent of patients. These results have mainly been reported in patients with intrinsic brain tumors. A few authors have reported longer progression-free survival for patients who had iMRI-guided surgery. There is also some evidence that iMRI use reduces hospital length of stay and costs.
IMRI has passed its toddler stage. We should no longer be content to stand around and coo admiringly at the few clever things it can do. If intraoperative imaging is to become part of mainstream neurosurgical routine, it has to become easier and cheaper to use. The laudable early enthusiasm for this amazing technology must morph into a mature assessment of the actual benefits that it may (or may not) confer. Progress toward these ends is evident in the convergence that has already occurred in iMRI systems. "High-field" devices have become more user-friendly and provide integrated surgical navigation, while "low-field" systems have increased in power and imaging quality. (What they have not become is cheaper, with cost ranging from about $1.5 million to $5 million.)
The logic of intraoperative imaging is unavoidable. Who among us doesn't acquire a postoperative MRI? Who would not want to know, at the time of surgery, if the tumor is out, if the electrode is correctly placed, that there is no hematoma? For the foreseeable future, MRI will be the best possible means of obtaining this information, better by far than CT or ultrasound. The first decade of iMRI proved the concept; the next will have to prove its worth.
Intraoperative MRI: No Longer a Child
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This meeting marks the 75th anniversary and diamond jubilee celebration of the AANS. This innovative and celebratory meeting promises an exciting array of programming and events.
The scientific program features the latest technological innovations and scientific advances from all areas of neurosurgery, presented within the framework of the practical clinics, breakfast seminars, plenary sessions, scientific and section sessions. While this meeting highlights cutting-edge research and the latest advances in the field, it also offers a wonderful setting to reflect on the 75 years of tradition and excellence that have enabled the AANS to help move neurosurgery forward.
The entire program and details are available online at www.AANS.org. During the last several years, discussion about the definition and limits of stereotactic radiosurgery has attracted much attention. Heated arguments arose not only between representatives of different specialties but also within neurosurgery itself. Main concerns included two important issues: (1) can "radiosurgery" be delivered in more than one session, and, if so, (2) where does stereotactic radiosurgery delivered in multiple sessions end and stereotactic radiotherapy begin? In an attempt to answer these issues and reach consensus with our radiation oncology colleagues, the AANS and CNS created the Stereotactic Radiosurgery Task Force under the auspices of the AANS/CNS Washington Committee. The results of this task force's extensive work have now been published (Barnett et al., J Neurosurg 106:1-5, 2007) .
Monday
Based on a thorough review of history and the current state of stereotactic application of focused energy-the concept originally designed and implemented by Lars Leksell and subsequently modified by generations of neurosurgeons-the task force came up with the contemporary definition of stereotactic radiosurgery that was subsequently sanctioned by AANS, CNS and the American Society for Therapeutic Radiology and Oncology. This definition states:  Stereotactic Radiosurgery is a distinct discipline that utilizes externally generated ionizing radiation in certain cases to inactivate or eradicate (a) defined target(s) in the head or spine without the need to make an incision. The target is defined by high-resolution stereotactic imaging. To assure quality of patient care the procedure involves a multidisciplinary team consisting of a neurosurgeon, radiation oncologist, and medical physicist.  Stereotactic Radiosurgery (SRS) typically is performed in a single session, using a rigidly attached stereotactic guiding device, other immobilization technology and/or a stereotactic image-guidance system, but can be performed in a limited number of sessions, up to a maximum of five.  Technologies that are used to perform SRS include linear accelerators, particle beam accelerators and multisource Cobalt-60 units. In order to enhance precision, various devices may incorporate robotics and real time imaging.
Progress in radiobiology, development of new and improved devices, and broadened clinical indications for radiosurgery are sure to render this new definition outdated at some point. As Barnett and colleagues note, this process of evolution and our relationship to it was summarized by John F. Kennedy: "Change is the law of life. And those who look only to the past or present are certain to miss the future." 
